RAの呼吸器合併症はこう診る!こう治す!

出版社： 先端医学社
著者：
発行日： 2013-11-20
分野： 臨床医学：内科  >  呼吸器一般
ISBN： 9784884079369
電子書籍版： 2013-11-20 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

5,170 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

2,585 円(税込)

購入する

商品紹介

深刻化する関節リウマチ患者の呼吸器合併症につき、どう診断しどう治療するかをまとめた実践書。 今、関節リウマチ（RA）の呼吸器合併症は、RA患者が本来もつ免疫異常のために起こる問題に加えて強力な治療薬による修飾が加わり、頻度・深刻度の両面において最大の問題として浮かび上がってきている。本書は、RAの臨床の現場で細菌性肺炎から結核、非結核性抗酸菌症（NTM症）、ニューモシスチス肺炎（PCP）、間質性肺炎（IP）など、 現今問題となるほぼすべての呼吸器合併症について、どう診断しどう治療するかを、特徴的な25点の参考症例解説とあわせ、エビデンスに依拠して解説した。RAの日常診療の現場で必携の1冊。（付録CD-ROM - 症例画像集）

目次

  • RAの呼吸器合併症はこう診る！こう治す！

    ―目次―

    Part1 総論
    　1．?関節リウマチと肺合併症―基本的な考え方―
    　2．?VISUAL REVIEW 生物学的製剤を使うと
    　　　　なぜ肺感染症が起きやすくなるのか？

    Part 2　 各論
    　1．気管支拡張症
    　2．細菌性肺炎
    　3．抗酸菌感染症
    　4．ニューモシスチス肺炎（急性びまん性肺病変の一つとして）
    　5．薬剤性肺障害
    　6．間質性肺炎
    　7．器質化肺炎
    　8．末梢気道病変

    付録CD-ROM - 症例画像集

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

はじめに～RA治療の現状～

P.17 掲載の参考文献
1) Yamanaka H, Seto Y, Tanaka E et al:Management of rheumatoid arthritis:the 2012 perspective. Mod Rheumatol 23:1-7, 2013
PubMed
2) Haraoui B, Smolen JS, Aletaha D et al;Treat to Target Taskforce.:Treating Rheumatoid Arthritis to Target:multinational recommendations assessment questionnaire. Ann Rheum Dis 70:1999-2002, 2011
PubMed
3) Smolen JS, Landewe R, Breedveld FC et al:EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 69:964-975, 2010
PubMed
4) Momohara S. Ikari K, Mochizuki T et al:Declining use of synovectomy surgery for patients with rheumatoid arthritis in Japan. Ann Rheum Dis 68:291-292, 2009
PubMed
5) Tanaka E, Hoshi D, Igarashi A et al:Analysis of direct medical and nonmedical costs for care of rheumatoid arthritis patients using the large cohort database, IORRA. Mod Rheumatol 23:742-751, 2012
PubMed
6) Gomez-Reino JJ, Carmona L, Valverde VR et al:Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk:a multicenter active-surveillance report. Arthritis Rheum 48:2122-2127, 2003
 
7) Takeuchi T, Tatsuki Y, Nogami Y et al:Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis 67:189-194, 2008
PubMed
8) Komano Y, Harigai M, Koike R et al:Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab:a retrospective review and case-control study of 21 patients. Arthritis Rheum 61:305-312, 2009
PubMed
9) Nakajima A, Saito K, Kojima T et al:No increased mortality in patients with rheumatoid arthritis treated with biologics:results from the biologics register of six rheumatology institutes in Japan. Mod Rheumatol 23:945-952, 2013
PubMed
10) 山中寿:関節リウマチ. 内科学第10版, 矢崎義雄 総編集, 朝倉書店, 東京, 2013, pp.1252-1258
 

Part 1 総論

P.30 掲載の参考文献
1) Doran MF, Crowson CS, Pond GR et al:Frequency of infection in patients with rheumatoid arthritis compared with controls:a population-based study. Arthritis Rheum 46:2287-2293, 2002
PubMed
2) Nakajima A, Inoue E, Tanaka E et al:Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA. Scand J Rheumatol 39:360-367, 2010
PubMed
3) Nakajima A, Saito K, Kojima T et al:No increased mortality in patients with rheumatoid arthritis treated with biologics:results from the biologics register of six rheumatology institutes in Japan. Mod Rheumatol 23:945-952, 2013
PubMed
4) 高柳昇, 土屋裕, 徳永大道ほか:関節リウマチに合併した肺感染症の検討. 日呼吸会誌 45:465-473, 2007
Medical*Online
5) Listing J, Strangfeld A, Kary S et al:Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 52:3403-3412, 2005
PubMed
6) Galloway JB, Hyrich KL, Mercer LK et al:Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment:updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology (Oxford) 50:124-131, 2011
PubMed
7) Wolfe F, Caplan L, Michaud K:Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia:associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Arthritis Rheum 54:628-634, 2006
PubMed
8) Remy-Jardin M, Remy J, Cortet B et al:Lung changes in rheumatoid arthritis:CT findings. Radiology 193:375-382, 1994
PubMed
9) Mori S, Cho I, Koga Y et al:Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol 35:1513-1521, 2008
PubMed
10) Fuschillo S, De Felice A, Balzano G:Mucosal inflammation in idiopathic bronchiectasis:cellular and molecular mechanisms. Eur Respir J 31:396-406, 2008
PubMed
11) Cortet B, Perez T, Roux N et al:Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis 56:596-600, 1997
PubMed
12) Swinson DR, Symmons D, Suresh U et al:Decreased survival in patients with co-existent rheumatoid arthritis and bronchiectasis. Br J Rheumatol 36:689-691, 1997
PubMed
13) McGuinness G, Naidich DP:CT of airways disease and bronchiectasis. Radiol Clin North Am 740:1-19, 2002
 
14) 武村民子:関節リウマチにおける肺病変の病理像. 日胸臨 66:470-484, 2007
Medical*Online
15) Yousem SA, Colby TV, Carrington CB:Follicuiar bronchitis/bronchiolitis. Hum Pathol l6:700-706, 1985
 
16) Rangel-Moreno J, Hartson L, Navarro C et al:Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 116:3183-3194, 2006
PubMed
17) 蛇澤晶, 朝川勝明, 杉野圭史ほか:閉塞性細気管支炎の病理. 呼吸 27:265-274, 2008
Medical*Online
18) Alarcon GS, Kremer JM, Macaluso M et al:Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group. Ann Intern Med 127:356-364, 1997
 
19) Tokuda H, Sakai F, Yamada HJ et al:Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumocystis pneumonia in acquired immunodeficiency syndrome:a multicenter study. Intern Med 47:915-923, 2008
 
20) Tasaka S, Tokuda H:Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies. J Infect Chemother 18:793-806, 2012
PubMed
21) Kameda H, Tokuda H, Sakai F et al:Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents:Importance of Pneumocystis pneumonia in Japan revealed by a multicenter study. Intern Med 50:305-313, 2011
PubMed
22) Komano Y, Harigai M, Koike R et al:Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab:a retrospective review and case-control study of 21 patients. Arthritis Rheum 61:305-312, 2009
PubMed
23) 徳田均:MTX肺炎. リウマチ科 42:516-524, 2009
 
24) Perez-Alvarez R, Perez-de-Lis M, Diaz-Lagares C et al:Interstitial lung disease induced or exacerbated by TNF-targeted therapies:analysis of 122 cases. Semin Arthritis Rheum 41:256-264, 2011
 
25) Geri G, Dadoun S, Bui T et al:Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases. BMC Infect Dis 11:304, 2011
PubMed
P.36 掲載の参考文献
1) Scott DL:Biologics-based therapy for the treatment of rheumatoid arthritis. Clin Pharmacol Ther 91:30-43, 2012
PubMed
2) Nakajima A, Saito K, Kojima T et al:No increased mortality in patients with rheumatoid arthritis treated with biologics:results from the biologics register of six rheumatology institutes in Japan. Mod Rheumatol 23:945-952, 2013
PubMed
3) Eisenhut M:Acute lower respiratory tract infection. N Engl J Med 358:2413-2414, 2008
PubMed
4) van der Poll T, Keogh CV, Buurman WA et al:Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med 155:603-608, 1997
PubMed
5) Rijneveld AW, Florquin S, Hartung T et al:Anti-tumor necrosis factor antibody impairs the therapeutic effect of ceftriaxone in murine pneumococcal pneumonia. J Infect Dis 188:282-285, 2003
PubMed
6) 瀬戸真太郎, 辻村邦夫, 小出幸夫:結核菌の細胞内寄生メカニズム. 日臨 69:1373-1377, 2011
Medical*Online
7) Murphy KM:Janeway's Immunobiology, 8th ed., Garland Science. New York, 2011, pp.377-381
 
8) Bruns H, Meinken C, Schauenberg P et al:Anti-TNF immunotherapy reduces CD8+ T cell-mediated anti-microbial activity against Mycobacterium tuberculosis in humans. J Clin Invest 119:1167-1177, 2009
 
9) Miller EA, Ernst JD:Anti-TNF immunotherapy and tuberculosis reactivation:another mechanism revealed. J Clin Invest 119:1079-1082, 2009
PubMed
10) 森俊輔, 濱本淳二, 杉本峯晴:関節リウマチ治療に伴うニューモシスティス肺炎-早期診断と発症予防. 呼吸 31:409-417, 2012
Medical*Online
11) Gigliotti F, Wright TW:Immunopathogenesis of Pneumocystis carinii pneumonia. Expert Rev Mol Med 7:1-16, 2005
PubMed

Part 2 各論

P.43 掲載の参考文献
1) Rosen MJ:Chronic Cough Due to Bronchiectasis. ACCP Evidence-Based Clinical Practice Guidelines. Chest 129(1 suppl):122S-131S, 2006
 
2) Mori S, Cho I, Koga Y et al:Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol 35:1513-1521, 2008
PubMed
3) Pasteur MC, Bilton D, Hill AT:British Thoracic Society Bronchiectasis non-CF Guideline Group:British Thoracic Society guideline for non-CF bronchiectasis. Thorax 65(suppl 1):i1-i58, 2010
 
4) Geri G, Dadoun S, Bui T et al:Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases. BMC Infect Dis 11:304, 2011
PubMed
5) Demoruelle MK, Weisman MH, Simonian PL et al:Brief report:airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis:early injury or initiating site of autoimmunity? Arthritis Rheum 64:1756-1761, 2012
PubMed
6) Tsuchiya Y, Takayanagi N, Sugiura H et al:Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur Respir J 37:1411-1417, 2011
PubMed
7) 高柳昇, 土屋裕, 徳永大道ほか:関節リウマチに合併した肺感染症の検討. 日呼吸会誌 45:465-473, 2007
Medical*Online
8) Swinson DR, Symmons D, Suresh U et al:Decreased survival in patients with co-existent rheumatoid arthritis and bronchiectasis. Br J Rheumatol 36:689-691, 1997
PubMed
9) Nakajima A, Inoue E, Tanaka E et al:Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA. Scand J Rheumatol 39:360-367, 2010
PubMed
10) 大河内康実, 徳田均:細気管支炎・気管支拡張症. リウマチ科 46:472-479, 2011
 
P.53 掲載の参考文献
1) Smitten AL, Choi HK, Hochberg MC et al:The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol 35:387-393, 2008
PubMed
2) Galloway JB, Hyrich KL, Mercer LK et al:Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment:updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology (Oxford) 50:124-131, 2011
PubMed
3) Takeuchi T, Kameda H:The Japanese experience with biologic therapies for rheumatoid arthritis. Nat Rev Rheumatol 6:644-652, 2010
PubMed
4) Nakajima A, Saito K, Kojima T et al:No increased mortality in patients with rheumatoid arthritis treated with biologics:results from the biologics register of six rheumatology institutes in Japan. Mod Rheumatol 23:945-952, 2013
PubMed
5) 高柳昇, 土屋裕, 徳永大道ほか:関節リウマチに合併した肺感染症の検討. 日呼吸会誌 45:465-473, 2007
Medical*Online
6) Remy-Jardin M, Remy J, Cortet B et al:Lung changes in rheumatoid arthritis:CT findings. Radiology 193:375-382, 1994
PubMed
7) Mori S, Cho I, Koga Y et al:Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol 35:1513-1521, 2008
PubMed
8) Tubach F, Ravaud P, Salmon-Ceron D et al:Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-α antagonists. Clin Infect Dis 43:e95-e100, 2006
 
9) 日本呼吸器学会呼吸器感染症に関するガイドライン作成委員会編, 成人市中肺炎診療ガイドライン, 2005年10月
 
10) Gotfried MH, Grossman RF:Short-course fluoroquinolones in acute exacerbations of chronic bronchitis. Expert Rev Respir Med 4:661-672, 2010
PubMed
P.59 掲載の参考文献
木田陽子ほか:エタネルセプト(ETN)投与中に発症した巨大空洞形成性肺炎球菌肺炎の1例. 日呼吸会誌 47:320-325, 2009
Medical*Online
P.70 掲載の参考文献
1) Wolfe F, Michaud K, Anderson J et al:Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum 50:372-379, 2004
PubMed
2) 森本耕三:NTMの日本と世界における疫学の現状. 第87回日本結核病学会総会シンポジウム, 2012
 
3) 天野宏一:感染防御におけるTNFの役割. リウマチ科 31:412-418, 2004
 
4) Solovic I, Sester M, Gomez-Reino JJ et al:The risk of tuberculosis related to tumour necrosis factor antagonist therapies:a TBNET consensus statement. Eur Respir J 36:1185-1206, 2010
PubMed
5) 日本結核病学会非結核性抗酸菌症対策委員会, 日本呼吸器学会感染症・結核学術部会:肺非結核性抗酸菌症診断に関する指針-2008年. 結核 83:525-526, 2008
 
6) 森俊輔, 杉本峯晴:関節リウマチの生物学的製剤療法に伴う肺非結核性抗酸菌症. 呼吸 31:883-890, 2012
Medical*Online
7) Winthrop KL, Chang E, Yamashita S et al:Nontuberculous mycobacteria infections and anti-tumor necrosis factor-α therapy. Emerg Infect Dis 15:1556-1561, 2009
 
8) Mori S, Tokuda H, Sakai F et al:Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents:a retrospective multicenter study in Japan. Mod Rheumatol 22:727-737, 2012
PubMed
9) 徳田均:生物学的製剤使用中の呼吸器感染症の現状と背景, 頻度, リスクを探る. 分子リウマチ治療 6:161-165, 2013
Medical*Online
P.88 掲載の参考文献
1) 五野貴久:ニューモシスチス肺炎-非HIV症例を中心に. 医のあゆみ 237:171-175, 2011
Medical*Online
2) Thornas CF Jr, Limper AH:Pneumocystis pneumonia. N Engl J Med 350:2487-2498, 2004
 
3) Vargas SL, Hughes WT, Santolaya ME et al:Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin lnfect Dis 32:855-861, 2001
 
4) Shimizu Y, Sunaga N, Dobashi K et al:Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization:a prospective study. BMC Infect Dis 9:47, 2009
PubMed
5) Mekinian A, Durand-Joly I, Hatron PY et al:Pneumocystis jirovecci colonization in patients with systemic autoimmune diseases:prevalence, risk factors of colonization and outcome. Rheumatology (Oxford) 50:569-577, 2011
 
6) Latouche S, Lacube P, Maury E et al:Pneumocystis jirovecii dihydropteroate synthase genotypes in French patients with pneumocystosis:a 1998-2001 prospective study. Med Mycol 41:533-537, 2003
PubMed
7) Mori S, Sugimoto M:Pneumocystis jirovecci infection:an emerging threat to patients with rheumatoid arthritis. Rheumatology (Oxford) 51:2120-2130, 2012
 
8) Benfield TL, Vestbo J, Junge J et al:Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 151:1058-1062, 1995
PubMed
9) Koike T, Harigai M, Inokuma S et al:Postmarketing surveillance of the safety and effectiveness of etanercept in Japan. J Rheumatol 36:898-906, 2009
PubMed
10) Chen W, Havell EA, Harmsen AG:Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. lnfect Immun 60:1279-1284, 1992
PubMed
11) Takeuchi T, Tatsuki Y, Nogami Y et al:Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis 67:189-194, 2008
PubMed
12) Limper AH, Offord KP, Smith TF et al:Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 140:1204-1209, 1989
PubMed
13) 徳田均:非AIDS症例におけるニューモシスチス肺炎. 日胸臨 69:112-123, 2010
Medical*Online
14) Tokuda H, Sakai F, Yamada H et al:Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumocystis pneumonia in acquired immunodeficiency syndrome:a multicenter study. Intern Med 47:915-923, 2008
PubMed
15) Tasaka S, Hasegawa N, Kobayashi S et al:Serum indicators for the diagnosis of pneumocystis pneumonia. Chest 131:1173-1180, 2007
PubMed
16) Kameda H, Tokuda H, Sakai F et al:Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents:importance of Pneumocystis pneumonia in Japan revealed by a multicenter study. Intern Med 50:305-313, 2011
PubMed
17) Tasaka S, Tokuda H:Pneumocystis jirovecci pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies. J Infect Chemother 18:793-806, 2012
 
18) Harigai M, Koike R, Miyasaka N:Pneumocystis Pneumonia under Anti-Tumor Necrosis Factor Therapy (PAT) Study Group:Pneumocystis pneumonia associated with infliximab in Japan. N Engl J Med 357:1874-1876, 2007
 
19) 徳田均:生物学的製剤使用中の呼吸器感染症の現状と背景, 頻度, リスクを探る. 分子リウマチ治療 6:161-165, 2013
Medical*Online
P.103 掲載の参考文献
1) 薬剤性肺障害の診断・治療の手引き, 日本呼吸器学会薬剤性肺障害の診断・治療の手引き作成委員会編, メディカルレビュー社, 東京, 2012
 
2) 萩原清文, 佐藤健夫, 秋山修ほか:メトトレキサートに対するリンパ球刺激試験:関節リウマチ患者を対象とした特異度の検討と考察. アレルギーの臨 26:46-50, 2006
 
3) Hirata S, Hattori N, Kumagai K et al:Lymphocyte transformation test is not helpful for the diagnosis of methotrexate-induced pneumonitis in patients with rheumatoid arthritis. Clin Chim Acta 407:25-29, 2009
 
4) 徳田均:関節リウマチの肺病変. Evidence based medicineを活かす膠原病・リウマチ診療 (第3版), 東京女子医科大学附属膠原病リウマチ痛風センター編, メジカルビュー社, 東京, 2013, pp.224-235
 
5) Shidara K, Hoshi D, Inoue E et al:Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA. Mod Rheumatol 20:280-286, 2010
 
6) Furukawa H, Oka S, Shimada K et al:HLA-A*31:01 and methotrexate-induced interstitial lung disease in Japanese rheumatoid arthritis patients:a multi-drug hypersensitivity marker? Ann Rheum Dis 72:153-155, 2013
 
7) Vigne C, Tebib JG, Pacheco Y et al:Sarcoidosis:an underestimated and potentially severe side effect of anti-TNF-alpha therapy. Joint Bone Spine 80:104-107, 2013
PubMed
P.115 掲載の参考文献
1) Nakajima A, Inoue E, Tanaka E et al:Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA. Scand Rheumatol 39:360-367, 2010
PubMed
2) 中島亜矢子, 小嶋俊久, 福田亙ほか:ワークショップ/関節リウマチの予後予測因子(1)-生物学的製剤にて加療された関節リウマチ患者の生命予後は悪化しない. 第56回日本リウマチ学会総会・学術集会・第21回国際リウマチシンポジウム, プログラム・抄録集:296, 2012
 
3) Gabbay E, Tarala R, Will R et al:Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 156:528-535, 1997
PubMed
4) Habib HM, Eisa AA, Arafat WR et al:Pulmonary involvement in early rheumatoid arthritis patients. Clin Rheumatol 30:217-221, 2011.
PubMed
5) Bongartz T, Nannini C, Medina-Velasquez YF et al:Incidence and mortality of interstitial lung disease in rheumatoid arthritis. A population-based study. Arthritis Rheum 62:1583-1591, 2010
PubMed
6) Koduri G, Norton S, Young A et al:lnterstitial lung disease has a poor prognosis in rheumatoid arthritis:results from an inception cohort. Rheumatology (Oxford) 49:1483-1489, 2010
 
7) Shidara K, Hoshi D, Inoue E et al:Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA. Mod Rheumatol 20:280-286, 2010
 
8) 武村民子:関節リウマチにおける肺病変の病理像. 日胸臨 66:470-484, 2007
Medical*Online
9) Flaherty KR, Travis WD, Colby TV et al:Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 164:1722-727, 2001
PubMed
10) Nicholson AG, Fulford LG, Colby TV et al:The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 166:173-177, 2002
PubMed
11) Flaherty KR, Colby TV, Travis WD et al:Fibroblastic foci in usual interstitial pneumonia:Idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 167:14101415, 2003
 
12) Song JW, Do KH, Kim MY et al:Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest 136:23-30, 2009
PubMed
13) Park JH, Kim DS, Park IN et al:Prognosis of fibrotic interstitial pneumonia. Idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 175:705-711, 2007
PubMed
14) Kim EJ, Elicker BM, Maldonado F et al:Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 35:1322-1328, 2010
PubMed
15) Tsuchiya Y, Takayanagi N, Sugiura H et al:Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur Respir J 37:1411-1417, 2011
PubMed
16) Lee HK, Kim DS, Yoo B et al:Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 127:2019-2027, 2005
PubMed
17) Tanaka N, Kim JS, Newell JD et al:Rheumatoid arthritis-related lung diseases:CT findings, Radiology 232:81-91, 2004
PubMed
18) Yousem SA, Colby TV, Carrington CB:Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 131:770-777, 1985
PubMed
19) Nakamura Y, Suda T, Kaida Y et al:Rheumatoid lung disease:prognostic analysis of 54 biopsy-proven cases. Respir Med 106:1164-1169, 2012
PubMed
20) Mori S, Cho I, Koga Y et al:Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol 35:1513-1521, 2008
PubMed
21) Park IN, Kim DS, Shim TS et al:Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 132:214-220, 2007
PubMed
22) Hagiwara K, Sato T, Takagi-Kobayashi S et al:Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis. J Rheumatol 34:1151-1154, 2007
PubMed
P.128 掲載の参考文献
1) Cordier JF:Cryptogenic organising pneumonia. Eur Respir J 28:422-446, 2006
PubMed
2) 徳田均:膠原病におけるCOPの診断と治療. リウマチ科 42:175-182, 2009
 
3) Epler GR, Colby TV, McLoud TC et al:Bronchiolitis obliterans organizing pneumonia. N Engl J Med 312:152-158, 1985
PubMed
4) American Thoracic Society;European Respiratory Society:American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the idiopathic interstitial pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165:277-304, 2002
 
5) 田中良一:器質化肺炎とリウマチ性疾患. 分子リウマチ 4:28-34, 2007
Medical*Online
6) Mori S, Cho I, Koga Y et al:A simultaneous onset of organizing pneumonia and rheumatoid arthritis, along with a review of the literature. Mod Rheumatol 18:60-66, 2008
PubMed
7) Nagai S, Handa T, Ito Y et al:Bronchoalveolar lavage in idiopathic interstitial lung diseases. Semin Respir Crit Care Med 28:496-503, 2007
PubMed
8) Cho SK, Oh IH, Park CK et al:Etanercept induced organizing pneumonia in a patient with rheumatoid arthritis. Rheumatol Int 32:1055-1057, 2012
 
P.140 掲載の参考文献
1) Geddes DM, Corrin B, Brewerton DA et al:Progressive airway obliteration in adults and its association with rheumatoid disease. Q J Med 46:427-444, 1977
PubMed
2) Geddes DM, Webley M, Emerson PA:Airways obstruction in rheumatoid arthritis. Ann Rheum Dis 38:222-225, 1979
PubMed
3) Mori S, Koga Y, Sugimoto M:Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis. Respir Med 106:1591-1599, 2012
PubMed
4) Mori S, Koga Y, Sugimoto M:Small airway obstruction in patients with rheumatoid arthritis. Mod Rheumatol 21:164-173, 2011
PubMed
5) 武村民子:関節リウマチにおける肺病変の病理像. 日胸臨 66:470-484, 2007
Medical*Online
6) Lyle WH:D-penicillamine and fatal obliterative bronchiolitis, Br Med J 1:105, 1977
PubMed
7) Wolfe F, Schurle DR, Lin JJ et al:Upper and lower airway disease in penicillamine treated patients with rheumatoid arthritis. J Rheumatol 10:406-410, 1983
PubMed
8) Rangel-Moreno J, Hartson L, Navarro C et al:Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 116:3183-3194, 2006
PubMed
9) Demoruelle MK, Weisman MH, Simonian PL et al:Brief report:airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis:early injury or initiating site of autoimmunity? Arthritis Rheum 64:1756-1761, 2012
PubMed
10) Yousem SA, Colby TV, Carrington CB:Follicular bronchitis/bronchiolitis. Hum Pathol 16:700-706, 1985
PubMed
11) 蛇澤晶, 朝川勝明, 杉野圭史ほか:閉塞性細気管支炎の病理. 呼吸 27:265-274, 2008
Medical*Online
12) 佐藤篤彦, 妹川史朗, 豊嶋幹生:厚生省特定疾患びまん性肺疾患調査研究班・平成5年度研究報告書, 74-76, 1994
 

書評

最近チェックした商品履歴

Loading...